NCT03598309 2026-02-27
Phase II Trial to Modulate Intermediate Endpoint Biomarkers in Former and Current Smokers
H. Lee Moffitt Cancer Center and Research Institute
Phase 2 Active not recruiting
Clinical Trials
20 trialsNCT03169790 2025-02-24
QUILT-3.052: NANT Non-Hodgkin Lymphoma (NHL) Vaccine: Combination Immunotherapy in Subjects With Relapsed CD20-positive NHL
ImmunityBio, Inc.
Phase 1/2 Withdrawn
NCT03167164 2025-02-21
QUILT-3.045: NANT Merkel Cell Carcinoma (MCC) Vaccine: Combination Immunotherapy in Subjects With MCC Who Have Progressed on or After PD-L1 Therapy
ImmunityBio, Inc.
Phase 1/2 Withdrawn
NCT03167177 2025-02-21
QUILT-3.046: NANT Melanoma Vaccine: Combination Immunotherapy in Subjects With Melanoma Who Have Progressed On or After Chemotherapy and PD-1/PD-L1 Therapy
ImmunityBio, Inc.
Phase 1/2 Withdrawn
NCT03169738 2025-02-21
QUILT-3.044: NANT Non-small Cell Lung Cancer (NSCLC) Vaccine: Combination Immunotherapy in Subjects With NSCLC Who Have Progressed After Treatment With PD-1/PD-L1 Inhibitors
ImmunityBio, Inc.
Phase 1/2 Withdrawn
NCT03169777 2025-02-21
QUILT-3.050: NANT Colorectal Cancer (CRC) Vaccine: Combination Immunotherapy in Subjects With Recurrent or Metastatic CRC
ImmunityBio, Inc.
Phase 1/2 Withdrawn
NCT03197571 2025-02-21
QUILT-3.048: NANT Urothelial Cancer Vaccine: Combination Immunotherapy in Subjects With Urothelial Cancer Who Have Progressed on or After Chemotherapy and PD-1/PD-L1 Therapy
ImmunityBio, Inc.
Phase 1/2 Withdrawn
NCT03329248 2024-12-12
QUILT-3.060: NANT Pancreatic Cancer Vaccine: Molecularly Informed Integrated Immunotherapy in Subjects With Pancreatic Cancer Who Have Progressed on or After Standard-of-care Therapy
ImmunityBio, Inc.
Phase 1/2 Terminated
NCT03387098 2024-05-22
QUILT-3.070:Pancreatic Cancer Vaccine: Subjects With Pancreatic Cancer Who Have Progressed on or After Standard-of-care Therapy
ImmunityBio, Inc.
Phase 1/2 Terminated
NCT04268134 2024-02-29
ALTA
University of Michigan Rogel Cancer Center
Phase 2 Completed
NCT03831698 2023-06-01
Omega 3 Fatty Acids in Colorectal Cancer (CRC) Prevention in Patients With Lynch Syndrome (COLYNE)
University of Kansas Medical Center
Phase 2 Unknown
NCT01821833 2022-10-05
Omega-3 Fatty Acid in Treating Pain in Patients With Breast or Ovarian Cancer Receiving Paclitaxel
New Mexico Cancer Research Alliance
Phase NA Completed
NCT04907864 2021-06-01
MIRACLE
Kyunghee University Medical Center
Phase 2 Unknown
NCT02996240 2021-03-17
Breast, Omega 3 Free Fatty Acid, Ph 0
The University of Texas Health Science Center at San Antonio
Phase NA Completed
NCT01823991 2020-07-14
COGNUTRIN in Breast Cancer Survivors
H. Lee Moffitt Cancer Center and Research Institute
Phase EARLY_PHASE1 Completed
NCT01661764 2018-06-08
Fish Oil Supplementation, Nutrigenomics and Colorectal Cancer Prevention
Vanderbilt University Medical Center
Phase 2 Completed
NCT01784042 2017-05-09
Dietary Energy Restriction and Omega-3 Fatty Acids on Mammary Tissue
Milton S. Hershey Medical Center
Phase EARLY_PHASE1 Withdrawn
NCT00815685 2017-03-23
A Pilot Study of Eicosapentaenoic Acid (EPA) in Patients With Cancer Cachexia
H. Lee Moffitt Cancer Center and Research Institute
Phase NA Completed
NCT01252277 2016-07-21
Breast Cancer Risk Biomarkers in Premenopausal Women
University of Kansas Medical Center
Phase 2 Completed
NCT00930527 2014-07-23
Omega-3-Fatty Acid on Joint Symptoms Inducted by Aromatase Inhibitors
Columbia University
Phase 2 Terminated